Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Total Debt (2019 - 2023)

Historic Total Debt for Korro Bio (KRRO) over the last 5 years, with Q1 2023 value amounting to $11.7 million.

  • Korro Bio's Total Debt fell 2222.0% to $11.7 million in Q1 2023 from the same period last year, while for Mar 2023 it was $11.7 million, marking a year-over-year decrease of 2222.0%. This contributed to the annual value of $14.2 million for FY2022, which is 555.33% down from last year.
  • Per Korro Bio's latest filing, its Total Debt stood at $11.7 million for Q1 2023, which was down 2222.0% from $14.2 million recorded in Q4 2022.
  • Korro Bio's 5-year Total Debt high stood at $15.0 million for Q4 2020, and its period low was $180000.0 during Q4 2019.
  • Moreover, its 5-year median value for Total Debt was $15.0 million (2020), whereas its average is $12.2 million.
  • Its Total Debt has fluctuated over the past 5 years, first skyrocketed by 823333.33% in 2020, then crashed by 2222.0% in 2023.
  • Quarter analysis of 5 years shows Korro Bio's Total Debt stood at $180000.0 in 2019, then surged by 8233.33% to $15.0 million in 2020, then changed by 0.0% to $15.0 million in 2021, then decreased by 5.55% to $14.2 million in 2022, then dropped by 17.65% to $11.7 million in 2023.
  • Its last three reported values are $11.7 million in Q1 2023, $14.2 million for Q4 2022, and $15.0 million during Q3 2022.